HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alicia Buckler-White Selected Research

Viremia

1/2021Immunotherapy during the acute SHIV infection of macaques confers long-term suppression of viremia.
5/2010Generation of the pathogenic R5-tropic simian/human immunodeficiency virus SHIVAD8 by serial passaging in rhesus macaques.
7/2009Initiation of antiretroviral therapy 48 hours after infection with simian immunodeficiency virus potently suppresses acute-phase viremia and blocks the massive loss of memory CD4+ T cells but fails to prevent disease.
6/2009Improved survival in rhesus macaques immunized with modified vaccinia virus Ankara recombinants expressing simian immunodeficiency virus envelope correlates with reduction in memory CD4+ T-cell loss and higher titers of neutralizing antibody.
10/2007Human immunodeficiency virus type 1 derivative with 7% simian immunodeficiency virus genetic content is able to establish infections in pig-tailed macaques.
12/2003Macrophage-tropic simian/human immunodeficiency virus chimeras use CXCR4, not CCR5, for infections of rhesus macaque peripheral blood mononuclear cells and alveolar macrophages.
5/2002The ITAM in Nef influences acute pathogenesis of AIDS-inducing simian immunodeficiency viruses SIVsm and SIVagm without altering kinetics or extent of viremia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alicia Buckler-White Research Topics

Disease

22Infections
01/2021 - 01/2002
7Viremia
01/2021 - 05/2002
7Acquired Immunodeficiency Syndrome (AIDS)
11/2013 - 05/2002
3Virus Diseases (Viral Diseases)
07/2009 - 01/2002
2Lentivirus Infections
01/2017 - 05/2009
2Disease Progression
01/2016 - 12/2005
1Persistent Infection
01/2017
1Hepatitis A (Hepatitis, Infectious)
05/2016
1Neurocognitive Disorders (Clerambault Syndrome)
01/2016
1HIV Infections (HIV Infection)
02/2015
1Neoplasms (Cancer)
11/2012
1Chronic Fatigue Syndrome (Myalgic Encephalomyelitis)
11/2010
1Prostatic Neoplasms (Prostate Cancer)
11/2010
1Opportunistic Infections (Opportunistic Infection)
05/2010
1Thrombocytopenia (Thrombopenia)
04/2009
1Lymphadenopathy
05/2006
1Leukemia
03/2002

Drug/Important Bio-Agent (IBA)

6VaccinesIBA
05/2016 - 12/2003
5Neutralizing AntibodiesIBA
11/2013 - 03/2002
4Broadly Neutralizing AntibodiesIBA
01/2021 - 05/2016
4AntibodiesIBA
01/2018 - 04/2009
4Antiviral Agents (Antivirals)IBA
02/2015 - 12/2003
3Monoclonal AntibodiesIBA
05/2016 - 12/2005
2Immunoglobulins (Immunoglobulin)IBA
05/2016 - 03/2002
2Proteins (Proteins, Gene)FDA Link
02/2015 - 10/2007
2RNA (Ribonucleic Acid)IBA
05/2010 - 01/2002
2Indicators and Reagents (Reagents)IBA
05/2010 - 04/2005
2DNA (Deoxyribonucleic Acid)IBA
05/2009 - 01/2002
2Viral RNAIBA
12/2003 - 05/2002
1Histocompatibility Antigens Class IIBA
11/2012
1AIDS VaccinesIBA
08/2012
1Xenotropic and Polytropic Retrovirus ReceptorIBA
11/2010
1Synthetic Vaccines (Recombinant Vaccines)IBA
06/2009
1Viral DNAIBA
05/2009
1Cyclosporine (Ciclosporin)FDA LinkGeneric
08/2007
1AntigensIBA
01/2004
1Immunoglobulin G (IgG)IBA
12/2003
1nef Gene Products (nef Gene Product)IBA
05/2002
1Complement System Proteins (Complement)IBA
03/2002
1ApolipoproteinsIBA
03/2002
1Lipoproteins (Lipoprotein)IBA
03/2002
1DNA Nucleotidylexotransferase (Terminal Deoxynucleotidyl Transferase)IBA
01/2002
1Biotin (Vitamin H)FDA Link
01/2002

Therapy/Procedure

3Therapeutics
01/2017 - 07/2009
2Euthanasia (Mercy Killing)
08/2012 - 05/2010
1Immunotherapy
01/2021
1Art Therapy
01/2016